Concomitant novel ALK-SSH2, EML4-ALK and ARID2-ALK, EML4-ALK double-fusion variants and confer sensitivity to crizotinib in two lung adenocarcinoma patients, respectively #lymphoma #lymsm https://t.co/y0G5G2jFa0
2,454 followers
2,454 followers
Concomitant novel ALK-SSH2, EML4-ALK and ARID2-ALK, EML4-ALK double-fusion variants and confer sensitivity to crizotinib in two lung adenocarcinoma patients, respectively #lymphoma #lymsm https://t.co/I8ZqPbX28q
168 followers
Concomitant novel ALK-SSH2, EML4-ALK and ARID2-ALK, EML4-ALK double-fusion variants and confer sensitivity to crizotinib in two lung adenocarcinoma patients, respectively https://t.co/QBeWVHetxk https://t.co/T4NyYI7Of7